A NIPT is a type of blood test you can take if you’re pregnant to determine the sex of the baby and whether it might develop a genetic disorder, such as Down syndrome. A noninvasive prenatal test ...

In this interview, NewsMedical speaks with Iris Meng, Foetal Medicine Specialist at the Shanghai First Maternity and Infant Hospital in Shanghai, China, about the applications of non-invasive prenatal ...

DUBLIN--(BUSINESS WIRE)--The "Non-Invasive Prenatal Testing (NIPT) Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has ...

The NIPT (noninvasive prenatal testing) is a genetic test performed on pregnant women, in order to detect fetal chromosomal aneuploidies. It is based upon the testing of cell-free fetal DNA (cf-fDNA) ...

The first trimester can be a time of anxiety. In addition to the nausea, fear of miscarrying, and changes to your body and lifestyle, you have to navigate your genetic testing options. It's a personal ...

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Mexico Non-Invasive Prenatal Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ...

Bromodomain-containing protein 7 as tumour suppressor and prognostic biomarker in breast cancer. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I. This abstract does not include a ...

Australian Non-Invasive Prenatal Testing Market · GlobeNewswire Inc. Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Australia Non-Invasive Prenatal Testing Market Size and Share Analysis - Growth ...

High baseline lymphocyte count is a predictive biomarker of prolonged time to progression in patients with advanced solid tumors receiving checkpoint inhibitors. Evolution of radiomic features on ...

Eurofins Scientific (EUFI.PA), the global scientific leader in bioanalytical testing and the European leader in non-invasive prenatal testing (NIPT), announces that it has signed an agreement with ...